CHPA on third class of drugs
This article was originally published in The Tan Sheet
Executive Summary
Two-class system of Rx and OTC drug regulation is a "time-tested system that provides consumers with convenient, cost-effective and safe treatment options," trade group maintains in 1May 27 statement reaffirming its opposition to "third class, or so-called transition class" of drugs. 2"The Tan Sheet" May 26, 2003 (p. 5) suggested CHPA was re-assessing its long-standing opposition to the idea of a third class...
You may also be interested in...
Behind-The-Counter Drug Class “On The Table” At CHPA
The Consumer Healthcare Products Association appears to have softened its steadfast opposition to a possible behind-the-counter third class of drugs
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.